Featured
FDA approves Brukinsa for relapsed, refractory MCL
The Food and Drug Administration has approved zanubrutinib (Brukinsa) for the treatment of mantle cell lymphoma (MCL) in adult patients who have received at least one prior therapy.
Latest News
November 17, 2019
Most charity assistance programs do not cover prescriptions for uninsured patients
November 17, 2019
MDedge Hematology and Oncology
November 16, 2019
Adding polatuzumab extends survival in relapsed/refractory DLBCL
November 16, 2019
MDedge Hematology and Oncology
November 15, 2019
Feds propose new price transparency rules in health care
November 15, 2019
MDedge Hematology and Oncology
From the Editor
Dr. Matt Kalaycio tackles challenges in academic leadership and current controversies in the specialty.
Hard Questions
Dr. Ilana Yurkiewicz explores the human side of hematology, sharing patient encounters in her hem-onc fellowship.
How I Will Treat My Next Patient
Dr. Alan Lyss breaks down the latest study findings into practice-changing tips.
Conference Coverage
November 15, 2019
Serum test sheds light on Merkel cell carcinoma
November 15, 2019
MDedge Hematology and Oncology
November 14, 2019
Transfusion-related lung injury is on the rise in elderly patients
November 14, 2019
MDedge Hematology and Oncology
November 14, 2019
Nivolumab-ipilimumab combo has ‘robust’ clinical benefit in sorafenib-treated HCC patients
November 14, 2019
MDedge Hematology and Oncology
Drug Approvals
November 15, 2019
FDA approves treatment for sickle cell pain crises
November 15, 2019
MDedge Hematology and Oncology
November 15, 2019
FDA approves Brukinsa for relapsed, refractory MCL
November 15, 2019
MDedge Hematology and Oncology
November 8, 2019
FDA approves anemia treatment for transfusion-dependent beta thalassemia patients
November 8, 2019
MDedge Hematology and Oncology
November 8, 2019
Lung cancer on the decline, but still higher among men than women
November 8, 2019
MDedge Hematology and Oncology
Policy & Practice
November 17, 2019
Most charity assistance programs do not cover prescriptions for uninsured patients
November 17, 2019
MDedge Hematology and Oncology
November 15, 2019
Feds propose new price transparency rules in health care
November 15, 2019
MDedge Hematology and Oncology
November 14, 2019
Open enrollment 2020: HealthCare.gov activity down from last year
November 14, 2019
MDedge Hematology and Oncology
November 13, 2019
ACP recommends ways to address rising drug prices
November 13, 2019
MDedge Hematology and Oncology
Opinion
November 1, 2019
Disparity in endometrial cancer outcomes: What can we do?
November 1, 2019
MDedge Hematology and Oncology
